NDAORALCAPSULE
Approved
Jan 2013
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Data completeness
4/8 — Partial
VAZALORE (aspirin) by Bayer is [acetylsalicylic acid (asa)] inhibits prostaglandin synthesis resulting in inhibition of platelet aggregation for their lifespan of about 7-10 days. First approved in 2013.
Drug data last refreshed Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Vazalore is an oral aspirin capsule formulation (acetylsalicylic acid) that irreversibly inhibits COX-1 and platelet aggregation for 7-10 days by preventing thromboxane A2 synthesis. It is indicated for cardiovascular and cerebrovascular disease prevention, including coronary artery disease, myocardial infarction, stroke, and acute coronary syndrome, as well as perioperative thromboprophylaxis and select oncology indications.
Peak6.4 years to LOE
Vazalore is in peak lifecycle with stable competitive positioning in the well-established antiplatelet market, suggesting mature commercial operations and specialized team focus on differentiation and retention.
Mechanism of Action
[acetylsalicylic acid (ASA)] inhibits prostaglandin synthesis resulting in inhibition of platelet aggregation for their lifespan of about 7-10 days. The acetyl group of aspirin binds with a serine residue of cyclooxygenase-1 (COX-1) , resulting in irreversible inactivation of the enzyme. Inhibition…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban
Started Nov 2025
96 enrolled
Drug Drug Interaction (DDI)
Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma
Started Sep 2025
530 enrolled
Multiple MyelomaVenous Thromboembolism
INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)
Started Aug 2025
Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
Started Jul 2025
1,800 enrolled
Preterm DeliveryObstetrical Complications
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
Started Jun 2025
400 enrolled
Preterm BirthPreeclampsia
Worked on VAZALORE at Bayer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.